CLINICAL_TRIALS
trial_result
· 2013-06-03
Clinical Trial Update: Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma [Phase 2]
Summary
Phase 2 trial evaluating the combination of Pyrazoloacridine and carboplatin for recurrent glioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED